Results
38
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
38 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MED | US$18.59 | -14.6% | -72.2% | US$194.2m | US$16.50 | PE27x | E4.4% | 0% | ||
SPB | US$89.12 | -3.1% | 10.0% | US$2.5b | US$104.88 | PE25.2x | E14.1% | 1.9% | ||
INBP | US$0.30 | -5.7% | 20.0% | US$9.6m | n/a | PE21.1x | n/a | n/a | ||
ODD | US$48.39 | -0.6% | 9.8% | US$2.8b | US$52.63 | PE27.3x | E18.5% | n/a | ||
HNST | US$7.09 | -6.1% | 136.3% | US$750.1m | US$7.14 | PS1.9x | E62.8% | n/a | ||
AXIL | US$4.00 | 2.6% | -52.4% | US$27.2m | n/a | PE8.4x | n/a | n/a | ||
DQWS | US$0.037 | 0% | -47.7% | US$7.6m | n/a | PE105.6x | n/a | n/a | ||
USNA | US$36.28 | -5.8% | -29.9% | US$699.5m | US$46.50 | PE12.7x | E-0.7% | n/a | ||
NATR | US$15.65 | -3.9% | -11.6% | US$290.1m | US$22.00 | PE17x | E6.4% | 0% | ||
UG | US$9.87 | 1.5% | 20.6% | US$45.4m | n/a | PE13x | n/a | 6.1% | ||
SHOT | US$0.75 | -14.5% | -83.7% | US$48.3m | n/a | PS70.2x | n/a | n/a | ||
NHTC | US$4.11 | -12.7% | -27.1% | US$48.8m | n/a | PE62.6x | n/a | 19.5% | ||
WDFC | US$264.40 | -2.9% | 9.4% | US$3.6b | US$301.00 | PE51.6x | E8.9% | 1.3% | ||
LFVN | US$16.60 | 13.7% | 163.5% | US$206.5m | n/a | PE50.3x | S5.0% | 1.0% | ||
ELF | US$134.89 | -2.0% | -11.6% | US$7.9b | US$157.19 | PE70.4x | E25.0% | n/a | ||
ODC | US$90.95 | 12.8% | 26.8% | US$650.5m | n/a | PE15.6x | n/a | 1.4% | ||
CHD | US$105.80 | -1.2% | 14.1% | US$25.9b | US$105.92 | PE47.1x | E18.2% | 1.1% | ||
VERU | US$0.71 | -1.0% | -0.7% | US$115.0m | US$3.40 | PS6.2x | E14.5% | 0% | ||
THRN | US$10.19 | 0.1% | 128.5% | US$550.6m | US$8.60 | PE27.1x | E57.2% | n/a | ||
FLGC New | US$1.16 | -31.4% | -12.8% | US$16.3m | US$4.00 | PS0.2x | E80.6% | n/a | ||
FTLF | US$33.50 | 3.6% | 61.1% | US$155.6m | US$40.00 | PE18.4x | S9.2% | n/a | ||
IPAR | US$133.41 | -3.6% | -6.7% | US$4.4b | US$142.60 | PE28.4x | E7.9% | 2.2% | ||
ELAB | US$1.97 | -23.3% | -99.5% | US$6.3m | n/a | PS2.5x | n/a | n/a | ||
CENT | US$43.14 | 5.2% | -11.2% | US$2.3b | US$42.00 | PE26.2x | E13.9% | 25.1% |